Home > Insider Trading > Filing (0001104659-24-123809)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1377121	Protagonist Therapeutics Inc	PTGX	Pharmaceutical Preparations (2834)	980505495

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1398940	Md Arturo Molina	C/O Protagonist Therapeutics, Inc. 7707 Gateway Blvd., Suite 140 Newark CA 94560-1160	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-11-26	5,529	$8.04	51,973	No	4	M	Direct
Common Stock	Disposition	2024-11-26	5,529	$45.60	46,444	No	4	S	Direct
Common Stock	Acquisiton	2024-11-27	10,000	$8.04	56,444	No	4	M	Direct
Common Stock	Disposition	2024-11-27	10,000	$44.50	46,444	No	4	S	Direct
Common Stock	Acquisiton	2024-11-27	16,000	$8.04	62,444	No	4	M	Direct
Common Stock	Disposition	2024-11-27	16,000	$44.83	46,444	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-11-26	5,529	$0.00	5,529	$8.04
Common Stock	Stock Option (right to buy)	Disposition	2024-11-27	10,000	$0.00	10,000	$8.04
Common Stock	Stock Option (right to buy)	Disposition	2024-11-27	16,000	$0.00	16,000	$8.04

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
121,971	2032-11-15	No	4	M	Direct
111,971	2032-11-15	No	4	M	Direct
95,971	2032-11-15	No	4	M	Direct

Footnotes

The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.94. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $43.80 to $44.92. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $44.50 to $44.99. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The stock option represents a right to purchase a total of 127,500 shares of the Issuer's common stock, one quarter of which vested on November 7, 2023, with the remaining three quarters vesting in equal monthly installments through November 7, 2026, subject to the Reporting Person's continued service to the Issuer.